BOSTON PHARMA VIETNAM - THE PHARMACEUTICAL COMPANY IS CERTIFIED IN COMPLIANCE WITH THE GUIDELINES AND PRINCIPLES OF GOOD MANUFACTURING PRACTICES – EUROPEAN UNION (EU GMP)

Established in 2007, Boston Pharma is a leading pharmaceutical manufacturer that has achieved remarkable success in both the Vietnamese and international markets. The company aspires to become one of the "Top 10 Reputable Pharmaceutical Manufacturers."

In September 2023, Boston Pharma was officially awarded the EU-GMP certification by the Portuguese Drug Administration.

This certification marks a pivotal milestone in Boston Pharma's development, providing assurance of the company's product quality and new opportunities in both domestic and international pharmaceutical markets.

Boston Pharma factory at the Vietnam-Singapore Industrial Park (Binh Duong province)

EU-GMP (Good Manufacturing Practices - European Union) represents the European Union's stringent standards for good manufacturing practices. It is regarded as one of the highest quality standards and is detailed in Chapter 4 of the regulations governing the good manufacturing practices of advanced therapy medicinal products (ATMP).

The EU-GMP assessment includes evaluations of production line personnel, production and quality control equipment, compliance documentation, raw materials, and the company’s self-inspection processes.

Currently, Boston Pharma operates factories adhering to both EU-GMP and WHO-GMP standards at the Vietnam - Singapore Industrial Park (Binh Duong Province). These factories are equipped with nearly 400 state-of-the-art pieces of equipment from countries such as the UK, France, Germany, the USA, and Japan, facilitating an annual production capacity exceeding 1.5 billion product units. The product portfolio includes over 300 therapeutic categories, underscoring the company’s mission to deliver the best products to the market.

Production line at Boston Pharma’s EU-GMP-certified factory

To meet market demands, Boston Pharma is constructing a third factory with a floor area of 30,000 m2, featuring additional modern production lines to diversify its product offerings for both domestic consumption and export.

Moreover, Boston Pharma has established a GMP-compliant research center to facilitate the acceptance of advanced scientific research projects and the seamless transfer of research processes to production within its internationally certified factories.

In addition to its production capabilities, Boston Pharma places significant emphasis on human resource development. The company employs over 1,000 highly qualified, experienced, and dedicated staff who undergo continuous training to meet evolving job requirements.

With a comprehensive distribution network, a proficient sales team, and specialized vehicles, Boston Pharma's products are available in all 63 provinces and cities, ensuring quality comparable to European imports and striving to enhance customer care.

In line with current technology trends, Boston Pharma also focuses on investing in digital transformation and successfully applying AI artificial intelligence and enterprise system management platforms such as: SAP S4HANA, Boston Sale App, Voicebot AI call center system, Robot office,...

Despite numerous challenges, Boston Pharma is still committed to product quality. The brand is progressively earning the trust of partners, customers, medical experts, and patients both domestically and internationally, in alignment with its mission to "Create a Healthy Community".

Source: VTCNews